Stomach Cancer Trial, Recruiting NCT06926374 Sponsor: Chinese University of Hong Kong Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06926374
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

General requirements for all procedures:

  • People with a body mass index (a measure of body weight relative to height) below 35
  • People whose condition is suitable for minimally invasive (keyhole-style) robotic surgery
  • People who are willing to take part and have signed a consent form

For bowel (colorectal) cancer surgery:

  • People with a cancer or large non-cancerous growth in the large bowel or rectum that is suitable for minimally invasive surgery

For a specific type of rectal cancer surgery (transanal total mesorectal excision):

  • People with cancer in the middle or lower part of the rectum, located less than 12 cm from the opening of the bowel

For rectal prolapse surgery (rectopexy):

  • People diagnosed with rectal prolapse (where part of the rectum slips outside the body) or a related condition called enterocele, that has not been treated before and has no complications

For prostate cancer surgery:

  • People diagnosed with prostate cancer that has not spread to other parts of the body

For kidney removal surgery (total or partial nephrectomy):

  • People diagnosed with kidney cancer that has not spread to other parts of the body

For bladder removal surgery (radical cystectomy):

  • People diagnosed with bladder cancer that has not spread to other parts of the body

For stomach reflux or hiatal hernia surgery:

  • People diagnosed with a hiatal hernia (where part of the stomach pushes up through the diaphragm) and/or persistent acid reflux (heartburn) that is suitable for a surgical repair called fundoplication

For stomach cancer surgery (gastrectomy):

  • People diagnosed with a stomach tumour (either stomach cancer or a type called GIST) that is suitable for minimally invasive removal of part or all of the stomach

For oesophageal (food pipe) cancer surgery (esophagectomy):

  • People diagnosed with cancer of the oesophagus (food pipe) that is suitable for minimally invasive surgery

For gallbladder removal surgery (cholecystectomy):

  • People with gallstones causing symptoms, where a doctor has recommended keyhole gallbladder removal surgery

Who may not be able to join:

General exclusions applying to all procedures:

  • People for whom general anaesthesia is not safe
  • People with a serious other illness that significantly shortens life expectancy or makes surgery much riskier
  • People with an active infection that has not yet been treated
  • People with a blood clotting problem that cannot be corrected
  • People who have another type of cancer, or cancer that has spread to distant parts of the body
  • People who need emergency surgery
  • People in vulnerable groups, such as those with an intellectual disability or who are pregnant

For bowel (colorectal) cancer surgery:

  • People whose tumour has grown into surrounding structures (known as a T4 tumour)
  • People with a tumour that has come back after previous treatment
  • People who have had extensive prior abdominal surgery that would prevent keyhole surgery

For rectal cancer surgery (transanal total mesorectal excision):

  • People whose tumour has grown into surrounding structures (T4), or where the tumour is too close to the surgical margin even after pre-surgery treatment
  • People whose tumour requires removal of nearby organs at the same time
  • People whose tumour requires a particular type of operation that removes the anus (abdominoperineal resection), or whose tumour has returned after previous treatment
  • People with an early-stage tumour (T1) that could be removed with a smaller local procedure instead
  • People who have had extensive prior abdominal surgery

For rectal prolapse surgery (rectopexy):

  • People who have had extensive prior abdominal surgery that would prevent keyhole surgery

For prostate cancer surgery:

  • People who have previously had surgery on their prostate (such as a procedure called TURP)

For kidney removal surgery:

  • People who have previously had surgery on the same kidney
  • People with unusual or complex kidney anatomy (confirm with trial site)

For oesophageal (food pipe) cancer surgery:

  • People who have already had the maximum dose of combined chemotherapy and radiotherapy for their oesophageal cancer and now need a rescue (salvage) operation

For stomach reflux/hernia surgery and stomach cancer surgery:

  • People who have previously had open abdominal surgery (a large incision, rather than keyhole surgery) that would prevent minimally invasive surgery

For gallbladder removal surgery:

  • People currently experiencing acute cholecystitis (sudden, severe gallbladder inflammation)
  • People who have previously had any abdominal surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Simon SM Ng, MD, Chinese University of Hong Kong

Phone: +852-35051495

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
25 March 2025
Est. completion
1 April 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Conversion rate; Perioperative complications

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov